The authors treated 12 schizophrenic patients who had overt hallucinatory symptoms with intravenously administered naloxone hydrochloride, a narcotic antagonist purported to have antihallucinatory properties. They found no evidence of the effectiveness of naloxone in preventing hallucinations over that of placebo when administered in a randomized, double-blind fashion.
No takes yet. Share an insight, caveat, or question.
Kurland et al. (1977) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: